Page last updated: 2024-09-03

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Obesity

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bertelsen, CV; Cornea, A; Frazier, SED; Gerstenberg, MK; Guldbrandt, M; Hansen, AMK; John, LM; Lundh, S; Lykkesfeldt, J; Mercer, AJ; Niss, K; Petersen, N; Quintana, CD; Rekling, JC; Torz, L; Villaescusa, JC1
Quillet, R; Simonin, F1

Other Studies

2 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Obesity

ArticleYear
NPFF Decreases Activity of Human Arcuate NPY Neurons: A Study in Embryonic-Stem-Cell-Derived Model.
    International journal of molecular sciences, 2022, Mar-17, Volume: 23, Issue:6

    Topics: Animals; Arcuate Nucleus of Hypothalamus; Humans; Neurons; Neuropeptide Y; Obesity; Oligopeptides

2022
[The neuropeptide FF: a signal for M1 to M2 type switching in macrophages from the adipose tissue].
    Medecine sciences : M/S, 2018, Volume: 34, Issue:1

    Topics: Adipose Tissue; Animals; Humans; Inflammation; Macrophages; Mice; Obesity; Oligopeptides; Signal Transduction

2018